Pancreatic Cancer Research

ResearcherMünchen Klinik HarlachingActive in the last 2 years

Meinolf Karthaus

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-8724-7172; OpenAlex author ID A5113678499. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216). Last author DOI 10.1038/s41416-025-03188-x↗
  2. An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial. Co-author DOI 10.1186/s12943-025-02406-7↗
  3. Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial. Co-author DOI 10.1200/jco.22.01134↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thomas Jens Ettrich · 2 shared papers, 2025–2026 · strength 0.41
  2. Manfred Paul Lutz · 2 shared papers, 2025–2026 · strength 0.41
  3. Ruben R. Plentz · 1 shared paper, 2026 · strength 0.22
  4. Dirk Waldschmidt · 1 shared paper, 2026 · strength 0.22
  5. Rui Fang · 1 shared paper, 2025 · strength 0.19
  6. Tim Eiseler · 1 shared paper, 2025 · strength 0.19
  7. Phyllis F. Cheung · 1 shared paper, 2025 · strength 0.19
  8. Andrea Tannapfel · 1 shared paper, 2025 · strength 0.19
  9. Anton Lahusen · 1 shared paper, 2025 · strength 0.19
  10. Alexander Kleger · 1 shared paper, 2025 · strength 0.19
  11. Thomas Theodor Werner Seufferlein · 1 shared paper, 2025 · strength 0.19
  12. Jens Thomas Siveke · 1 shared paper, 2025 · strength 0.19
  13. Albrecht Stenzinger · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.